RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PHAT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Phathom Pharmaceuticals, Inc.
(Updated on Mar 28, 2024)

Buy candidate since Mar 22, 2024 Loss -3.63% PDF

The Phathom Pharmaceuticals, Inc. stock price fell by -3.89% on the last day (Thursday, 28th Mar 2024) from $11.05 to $10.62. During the last trading day the stock fluctuated 7.68% from a day low at $10.42 to a day high of $11.22. The price has risen in 7 of the last 10 days and is up by 36.68% over the past 2 weeks. Volume has increased on the last day by 124 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 875 thousand shares were bought and sold for approximately $9.30 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.64% during the next 3 months and, with a 90% probability hold a price between $9.31 and $14.57 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PHAT Signals & Forecast

The Phathom Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.27 and $9.15. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -3.89%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Phathom Pharmaceuticals, Inc. stock

Phathom Pharmaceuticals, Inc. finds support from accumulated volume at $10.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.80 between high and low, or 7.68%. For the last week, the stock has had daily average volatility of 12.49%.

Our recommended stop-loss: $10.17 (-4.20%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (PHAT) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Phathom Pharmaceuticals, Inc. to open at $10.75, and during the day (based on 14 day Average True Range), to move between $9.73 and $11.51, which gives a possible trading interval of +/-$0.89 (+/-8.42%) up or down from last closing price. If Phathom Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 16.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $10.69 (0.66%) than the support at $10.17 (4.24%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Phathom Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Phathom Pharmaceuticals, Inc. stock to perform well in the short-term.

Current score: 3.821 Buy Candidate Unchanged

Predicted Opening Price for Phathom Pharmaceuticals, Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$10.75 ( 1.26%) $10.62

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PHAT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 11.55 8.79 %
R2 11.25 5.91 %
R1 11.06 4.13 %
Current price: 10.62
Support S1 10.45 -1.62 %
S2 10.26 -3.40 %
S3 9.95 -6.28 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.02 3.77 %
R2 10.78 1.51 %
R1 10.69 0.659 %
Current price 10.62
Support S1 10.17 -4.24%
S2 9.29 -12.52%
S3 9.09 -14.41%

FAQ

What is the symbol for Phathom Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Phathom Pharmaceuticals, Inc. is PHAT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Phathom Pharmaceuticals, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Phathom Pharmaceuticals, Inc. stock to perform well in the short-term.

How to buy Phathom Pharmaceuticals, Inc. Stock?
Phathom Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Phathom Pharmaceuticals, Inc. Stock.

What's the current price of Phathom Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Phathom Pharmaceuticals, Inc. (PHAT) share was $10.62.

What is the 52-week high and low for Phathom Pharmaceuticals, Inc. Stock?
The 52-week high for Phathom Pharmaceuticals, Inc. Stock is $17.00 and the 52-week low is $6.07.

What is the market capitalization of Phathom Pharmaceuticals, Inc. Stock?
As of the 2024-03-28, the market capitalization of Phathom Pharmaceuticals, Inc. is 621.03M.

When is the next earnings date for Phathom Pharmaceuticals, Inc.?
The upcoming earnings date for Phathom Pharmaceuticals, Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re... PHAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT